A HER2-targeted antibody-novel DNA topoisomerase I inhibitor conjugate induces durable adaptive antitumor immunity by activating dendritic cells.
Tan X, Fang P, Li K, You M, Cao Y, Xu H, Zhu X, Wang L, Wei X, Wen H, Li W, Shi L, Sun X, Yu D, Zhu H, Wang Z, Liu D, Shen H, Zhou W, An M.
Tan X, et al. Among authors: shen h.
MAbs. 2023 Jan-Dec;15(1):2220466. doi: 10.1080/19420862.2023.2220466.
MAbs. 2023.
PMID: 37314961
Free PMC article.